CollPlant Biotechnologies Ltd
CLGN Nasdaq
SEC CIK 1631487
Follow CollPlant Biotechnologies
Weekly email: filings, results, news
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.4M | −$11.5M |
| FY24 | $515K | −$16.6M |
| FY23 | $11M | −$7M |
| FY22 | $299K | −$16.9M |
| FY21 | $15.6M | $237K |
| FY20 | $6.1M | −$5.8M |
| FY19 | $2.3M | −$11.2M |
| FY18 | $5M | −$6.2M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 64.8% | −484.3% | −484.6% |
| FY24 | −215.5% | −3349.7% | −3225% |
| FY23 | 81.8% | −68.5% | −64% |
| FY22 | −33.8% | −5718.1% | −5660.5% |
| FY21 | 87.2% | 0.4% | 1.5% |
| FY20 | 51.1% | −91.2% | −94.1% |
| FY19 | 18.9% | −329.2% | −481.6% |
| FY18 | 66.9% | −84.7% | −124.6% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$9.4M |
| FY24 | −$14.6M |
| FY23 | −$3.7M |
| FY22 | −$15M |
| FY21 | $1.1M |
| FY20 | −$4.9M |
| FY19 | −$7.2M |
| FY18 | −$2M |
| FY17 | - |
- CollPlant Biotechnologies
- Healthcare median
Show the numbers
| Year | CollPlant Biotechnologies | Healthcare median |
|---|---|---|
| FY25 | −484.6% | −40.6% |
| FY24 | −3225% | −60.7% |
| FY23 | −64% | −97.1% |
| FY22 | −5660.5% | −128.5% |
| FY21 | 1.5% | −129.2% |
| FY20 | −94.1% | −136.5% |
| FY19 | −481.6% | −133.7% |
| FY18 | −124.6% | −173.4% |
| FY17 | - | −176.7% |
News
No stories filed under CollPlant Biotechnologies yet - coverage appears here as the news feed clusters it.